IXHL · Incannex Healthcare Limited

Summary

Incannex Healthcare Inc. announced a partnership agreement with the AASM Foundation on March 25, 2026, joining the Corporate Recognition Program and sponsoring a Focused Projects Grant for Junior Investigators on sleep apnea research. This supports the company's IHL-42X program, which has positive Phase 2 results, FDA Fast Track designation, and upcoming DReAMzz Phase 2 study.

Key takeaways

• Entered Partnership Agreement with AASM Foundation on March 25, 2026
• Sponsoring Focused Projects Grant for Junior Investigators on sleep apnea, awarded in 2026
• IHL-42X received FDA Fast Track designation and positive Phase 2 results
• Patient dosing for DReAMzz Phase 2 crossover dose-optimisation study expected in coming months